Forecasting Emerging Pandemics with Transfer Learning and Location-aware News Analysis
Forecasting Emerging Pandemics with Transfer Learning and Location-aware News Analysis
复制标题
DOI:
10.1109/bigdata55660.2022.10020218
复制
发表时间:
2022-12
期刊:
影响因子:
--
通讯作者:
Jing Chen;Germán G. Creamer;Yue Ning
中科院分区:
文献类型:
--
作者:
Jing Chen;Germán G. Creamer;Yue Ning
Monitoring and forecasting epidemic diseases are of prime importance to public health organizations and policymakers in taking proper measures and adjusting prevention tactics. Early prediction is especially important to restrict the spread of emerging pandemics such as COVID-19. However, despite increasing research and development for various epidemics, several challenges remain unresolved. On the one hand, early-stage epidemic prediction for emerging new diseases is difficult because of data paucity and lack of experience. On the other hand, many existing studies ignore or fail to leverage the contribution of social factors such as news, geolocations, and climate. Even though some researchers have recognized the profound impact of social features, capturing the dynamic correlation between these features and pandemics requires an extensive understanding of heterogeneous formats of data and mechanisms. In this paper, we design TLSS, a neural transfer learning architecture for learning and transferring general characteristics of existing epidemic diseases to predict a new pandemic. We propose a new feature module to learn the impact of news sentiment and semantic information on epidemic transmission. We then combine this information with historical time-series features to forecast future infection cases in a dynamic propagation process. We compare the proposed model with several state-of-the-art statistics approaches and deep learning methods in epidemic prediction with different lead times of ground truth. We conducted extensive experiments on three stages of COVID-19 development in the United States. Our experiment demonstrates that our approach has strong predictive performance for COVID infection cases, especially with longer lead times.